Can-Fite BioPharma Ltd. logo

Can-Fite BioPharma Ltd. CANF

$ 2.14 0.45%
report update icon

Quarterly report 2025-Q4
added 05-13-2026

Country

israelIsrael

IPO year

-

Industry

Biotechnology

Stock Exchange

NYSE AMERICAN

Shares

1.65 M

Market Cap[1]

$ 3.52 M

EBITDA (LTM)

$ -9.93 M

P/E (LTM)

-0.373534

P/S (LTM)

9.064306

EPS (LTM)

-5.97

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
BeyondSpring BeyondSpring
BYSI
$ 0.79 2.12 % $ 32.5 M Nasdaq Capital Market usaUSA
Cabaletta Bio Cabaletta Bio
CABA
$ 2.08 4.0 % $ 209 M Nasdaq Global Select Market usaUSA
Capricor Therapeutics Capricor Therapeutics
CAPR
$ 7.78 0.11 % $ 362 M Nasdaq Capital Market usaUSA
Catalyst Biosciences Catalyst Biosciences
CBIO
$ 13.94 0.42 % $ 1.25 B Nasdaq Capital Market usaUSA
C4 Therapeutics C4 Therapeutics
CCCC
$ 2.99 1.36 % $ 248 M Nasdaq Global Select Market usaUSA
Codexis Codexis
CDXS
$ 1.39 2.21 % $ 121 M Nasdaq Global Select Market usaUSA
Cerus Corporation Cerus Corporation
CERS
$ 2.34 2.63 % $ 446 M Nasdaq Global Market usaUSA
Certara Certara
CERT
$ 10.07 7.59 % $ 1.62 B Nasdaq Global Select Market usaUSA
Cullinan Management Cullinan Management
CGEM
$ 16.04 3.42 % $ 966 M Nasdaq Global Select Market usaUSA
Compugen Ltd. Compugen Ltd.
CGEN
$ 2.31 0.43 % $ 216 M Nasdaq Global Market,SPB israelIsrael
Coherus BioSciences Coherus BioSciences
CHRS
$ 1.12 0.86 % $ 131 M Nasdaq Global Market usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
$ 32.59 2.97 % $ 2.16 B Nasdaq Global Select Market usaUSA
CollPlant Biotechnologies Ltd. CollPlant Biotechnologies Ltd.
CLGN
$ 3.41 1.46 % $ 41.6 M Nasdaq Capital Market israelIsrael
Cellectis S.A. Cellectis S.A.
CLLS
$ 1.41 0.48 % $ 141 M Nasdaq Global Market franceFrance
Cellectar Biosciences Cellectar Biosciences
CLRB
$ 1.67 0.56 % $ 4.36 M Nasdaq Capital Market usaUSA
CNS Pharmaceuticals CNS Pharmaceuticals
CNSP
$ 5.3 0.7 % $ 2.35 M Nasdaq Capital Market usaUSA
Cocrystal Pharma Cocrystal Pharma
COCP
$ 1.11 1.72 % $ 12.5 M Nasdaq Capital Market usaUSA
Collegium Pharmaceutical Collegium Pharmaceutical
COLL
$ 21.87 0.05 % $ 692 M Nasdaq Global Select Market usaUSA
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
CORT
$ 122.03 4.99 % $ 12.7 B Nasdaq Capital Market,SPB usaUSA
Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings
CRBP
$ 5.85 0.16 % $ 77.9 M Nasdaq Global Market usaUSA
Cardiff Oncology Cardiff Oncology
CRDF
$ 1.14 1.79 % $ 76.2 M Nasdaq Capital Market usaUSA
Curis Curis
CRIS
$ 0.79 0.1 % $ 10.4 M Nasdaq Global Market usaUSA
CorMedix CorMedix
CRMD
$ 7.26 0.97 % $ 523 K Nasdaq Global Market usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
$ 57.34 3.45 % $ 5.16 B Nasdaq Global Market,SPB schweizSchweiz
Corvus Pharmaceuticals Corvus Pharmaceuticals
CRVS
$ 10.74 0.09 % $ 848 M Nasdaq Global Market usaUSA
Champions Oncology Champions Oncology
CSBR
$ 4.97 0.61 % $ 68.7 M Nasdaq Capital Market usaUSA
CytomX Therapeutics CytomX Therapeutics
CTMX
$ 2.58 0.78 % $ 356 M Nasdaq Global Select Market usaUSA
Citius Pharmaceuticals Citius Pharmaceuticals
CTXR
$ 0.52 0.4 % $ 5.75 M Nasdaq Capital Market usaUSA
Cue Biopharma Cue Biopharma
CUE
$ 24.36 1.27 % $ 2.31 B Nasdaq Capital Market,SPB usaUSA
CEL-SCI Corporation CEL-SCI Corporation
CVM
$ 2.42 4.76 % $ 19.4 M NYSE American,SPB usaUSA
Cytokinetics, Incorporated Cytokinetics, Incorporated
CYTK
$ 62.7 0.2 % $ 7.53 M Nasdaq Global Select Market,SPB usaUSA
Daré Bioscience Daré Bioscience
DARE
$ 0.84 0.04 % $ 9.39 M Nasdaq Capital Market usaUSA
DBV Technologies S.A. DBV Technologies S.A.
DBVT
$ 10.44 0.47 % $ 1.46 B Nasdaq Global Select Market franceFrance
DiaMedica Therapeutics DiaMedica Therapeutics
DMAC
$ 8.42 2.31 % $ 396 M Nasdaq Capital Market usaUSA
Denali Therapeutics Denali Therapeutics
DNLI
$ 19.91 0.41 % $ 3.44 B Nasdaq Global Select Market,SPB usaUSA
Precision BioSciences Precision BioSciences
DTIL
$ 6.31 0.16 % $ 80.9 M Nasdaq Global Select Market usaUSA
Dyadic International Dyadic International
DYAI
$ 0.45 0.31 % $ 16.3 M Nasdaq Capital Market usaUSA
Editas Medicine Editas Medicine
EDIT
$ 2.79 6.49 % $ 248 M Nasdaq Global Select Market,SPB usaUSA
Edesa Biotech Edesa Biotech
EDSA
$ 3.91 1.3 % $ 22.2 M Nasdaq Capital Market usaUSA
Enlivex Therapeutics Ltd. Enlivex Therapeutics Ltd.
ENLV
$ 0.36 0.36 % $ 16.5 M Nasdaq Capital Market israelIsrael
Enanta Pharmaceuticals Enanta Pharmaceuticals
ENTA
$ 12.6 0.93 % $ 269 K Nasdaq Global Select Market,SPB usaUSA
Entera Bio Ltd. Entera Bio Ltd.
ENTX
$ 2.62 0.69 % $ 121 M Nasdaq Capital Market israelIsrael
Equillium Equillium
EQ
$ 1.45 2.84 % $ 83.1 M Nasdaq Global Market usaUSA
Eton Pharmaceuticals Eton Pharmaceuticals
ETON
$ 55.62 0.47 % $ 1.5 B Nasdaq Global Market usaUSA
Evogene Ltd. Evogene Ltd.
EVGN
$ 0.4 3.54 % $ 3.15 M Nasdaq Global Market israelIsrael
Exelixis Exelixis
EXEL
$ 58.85 0.79 % $ 16 B Nasdaq Global Select Market,SPB usaUSA
EyePoint Pharmaceuticals EyePoint Pharmaceuticals
EYPT
$ 3.15 0.62 % $ 231 K Nasdaq Global Market usaUSA
Fate Therapeutics Fate Therapeutics
FATE
$ 2.43 4.74 % $ 289 M Nasdaq Global Market,SPB usaUSA
Fortress Biotech Fortress Biotech
FBIO
$ 2.09 2.96 % $ 58.3 M Nasdaq Capital Market usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.